Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation
Revisiting nutritional support for allogeneic hematologic stem cell transplantation—a systematic review
Going home for the holidays? Take a shortcut!
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation
A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation
Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia
A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT
Clinical and biological markers of premature aging after autologous SCT in childhood cancer
Good responses but high TRM in adult patients after MSC therapy for GvHD
Persistent recipient-derived human adenovirus (HAdV) -specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation
Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients
Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors
Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series
Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients
Cord blood transplantation, a cost-effective alternative: a health-economic analysis of the National Swedish Cord Blood Bank
Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation
Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation
Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience
Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses